Allergy Asthma & Immunology Research

Allergy, Asthma & Immunology Research is a bimonthly, fully open-access journal issued by the Korean Academy of Asthma, Allergy and Clinical Immunology together with the Korean Academy of Pediatric Allergy and Respiratory Disease, founded in 2009 to report research on allergy, asthma and immunology, with a 2025 Journal Impact Factor of 4.3《过敏、哮喘与免疫学研究》（Allergy, Asthma & Immunology Research）是由韩国哮喘、变态反应与临床免疫学会与韩国小儿变态反应与呼吸疾病学会共同发行的完全开放获取双月刊，2009 年创刊，报道过敏、哮喘与免疫学领域的研究，2025 年期刊影响因子为 4.3。

Scope

• The journal features cutting-edge original research, brief communications and state-of-the-art reviews in the specialties of allergy, asthma and immunology该刊以过敏、哮喘与免疫学三个专科的前沿原创研究、简短通讯与最新综述为主要内容。
• Both clinical and experimental studies fall within its remit, and for many years it also carried instructive case reports临床研究与实验研究均在收录之列，多年来该刊还刊发具有教学意义的病例报告。
• Contemporary reviews summarize information for researchers and physicians working in the fields of allergy and immunology其当代综述为从事过敏与免疫学研究的学者和临床医生梳理领域信息。
• It also carries topics in practice and management, covering how allergic conditions are handled in everyday clinical work该刊还设有实践与管理方面的专题，讨论过敏性疾病在日常诊疗中的处理方式。
• Recent advances in equipment and techniques for clinicians concerned with the clinical manifestations of allergies and pediatric respiratory diseases form another stated interest面向关注过敏临床表现的临床医师与小儿呼吸疾病从业者，该刊还关注诊断设备与技术的最新进展。
• Editorials and letters to the editor explore controversial issues and encourage further discussion among physicians in allergy, immunology, pediatric respirology and related medical fields社论与致编辑函探讨争议性问题，鼓励过敏学、免疫学、小儿呼吸学及相关医学领域的医师进一步讨论。

History

• The journal was founded in 2009 and appeared quarterly until 2011该刊于 2009 年创刊，2009 至 2011 年期间为季刊。
• It became bimonthly from 2012, appearing in January, March, May, July, September and November of each year自 2012 年起改为双月刊，每年在一、三、五、七、九、十一月出版。
• The issue current at the time of writing is volume 18, number 5, of September 2026写作时最新一期为 2026 年 9 月的第 18 卷第 5 期。
• From January 2017 the journal has no longer accepted case reports, although clinically important cases may still be submitted in the form of a letter to the editor自 2017 年 1 月起，该刊不再接收病例报告，临床意义重大的个案仍可作为致编辑函投稿。
• Its content is distributed under the Creative Commons Attribution NonCommercial licence, version 4.0其内容以（Creative Commons Attribution NonCommercial）许可协议 4.0 版分发。
• It is indexed by PubMed, PubMed Central, KoreaMed, Synapse, KoMCI, Science Citation Index, Chemical Abstracts Service, CAB Abstracts, Global Health and Scopus该刊被（PubMed）、（PubMed Central）、（KoreaMed）、（Synapse）、（KoMCI）、（Science Citation Index）、（Chemical Abstracts Service）、（CAB Abstracts）、（Global Health）与（Scopus）收录。

Editors

• Professor Yoon-Seok Chang of Seoul National University serves as Editor-in-Chief现任主编为韩国首尔大学的（Yoon-Seok Chang）教授。
• Five Deputy Editors serve alongside him, namely Dong Hun Lee, Dong-Young Kim, Heung Woo Park and Hyun-Woo Shin of Seoul National University and Woo-Jung Song of the University of Ulsan其下设五位副主编，分别是首尔大学的（Dong Hun Lee）、（Dong-Young Kim）、（Heung Woo Park）与（Hyun-Woo Shin），以及蔚山大学的（Woo-Jung Song）。
• An Advisory Board spans Korea, the United States, France, Switzerland, the United Kingdom, Japan, Austria, China and Singapore顾问委员会成员的所在国遍及韩国、美国、法国、瑞士、英国、日本、奥地利、中国与新加坡。
• Forty Associate Editors, most of them at Korean universities such as Yonsei, Hanyang, Seoul National and Sungkyunkwan, also handle submissions另有四十位副编辑共同处理投稿，其中多数任职于延世大学、翰阳大学、首尔大学与成均馆大学等韩国高校。
• The wider Editorial Board includes Ioana Agache of Transylvania University, G. Walter Canonica of the University of Genoa, Marek L Kowalski of the Medical University of Lodz and Donald Y. M. Leung of National Jewish Health更广泛的编辑委员会成员包括特兰西瓦尼亚大学的（Ioana Agache）、热那亚大学的（G. Walter Canonica）、罗兹医科大学的（Marek L Kowalski）与（National Jewish Health）的（Donald Y. M. Leung）。
• Manuscripts are submitted through Editorial Manager, and the journal is edited and produced by XMLink, which also produces a printed edition稿件通过（Editorial Manager）系统提交，该刊由（XMLink）负责编辑与制作，并同时出版纸质版。